Skip to main content
Clinical Trials/NL-OMON54809
NL-OMON54809
Recruiting
Not Applicable

Endoscopic management of patients with high risk T1a and T1b N0M0 esophageal adenocarcinoma: a prospective multicenter registry - PREFER study

Academisch Medisch Centrum0 sites175 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
esophageal cancer
Sponsor
Academisch Medisch Centrum
Enrollment
175
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with high risk mucosal or submucosal EAC diagnosed in an ER
  • specimen, diagnosed by an expert gastrointestinal (GI) pathologist.
  • 2\. Signed informed consent.

Exclusion Criteria

  • 1\. Prior history of esophageal cancer (invasion of T1sm or deeper or HR T1a).
  • 2\. Synchronous esophageal squamous cell carcinoma
  • 3\. Suspicion on lymph node metastasis or distant metastasis on EUS, ultrasound
  • of the neck, CT\-thorax\-abdomen or PET\-CT during baseline measurement.
  • 4\. Tumor\-positive deep resection margin (R1\) in ER/ESD specimen
  • 5\. Patients unable to give signed informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal AdenocarcinomaSubmucosal Esophageal AdenocarcinomaBarrett EsophagusHigh-risk Mucosal Esophageal Adenocarcinoma
NCT03222635Amsterdam UMC225
Recruiting
Not Applicable
Endoscopic management for patients with serrated polyposis syndrome is feasible and effective : A prospective observational study at a tertiary center.C18Malignant neoplasm of colon
DRKS00005031Dr. Horst-Schmidt-KlinikKlinik für Gastroenterologie25
Completed
Not Applicable
Safety evaluation of high-risk endoscopic procedures on aspirin for high-risk patients of thromboembolism.Status requiring high-risk procedures in gastrointestinal tract during anti-platelet therapy.
JPRN-UMIN000009176Department of gastroenterology, The University of Tokyo.60
Active, not recruiting
Phase 1
Intensive endoscopic therapy compared with standard endoscopic therapy for newly diagnosed benign strictures in the esophagus that developed after esophageal resectioBenign esophagogastric anastomotic strictures after esophagectomyMedDRA version: 20.0Level: LLTClassification code 10030199Term: Oesophageal strictureSystem Organ Class: 100000004856MedDRA version: 20.0Level: LLTClassification code 10015449Term: Esophageal strictureSystem Organ Class: 100000004856MedDRA version: 20.0Level: PTClassification code 10030215Term: OesophagectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: LLTClassification code 10015460Term: EsophagectomySystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2016-001853-41-NLAcademic Medical Center89
Suspended
Not Applicable
Intensive endoscopic therapy versus standard treatment for untreated benign esophageal strictures resulting from excessive scar tissue formation after surgeryBenign esophageal stricturesAnastomotic stricturesEsophagectomyEndoscopic dilationEndoscopic incisionBenigne slokdarmstenosenNaadstenosenSlokdarmresectieEndoscopische dilatatieEndoscopische incisie
NL-OMON29569Academic Medical Center89